glp-1 novo asks FDA to prevent compounders from making knockoffs Ozempic is first GLP-1 drug

For only a few dollars a month, youll get tasty, healthy meal ideas that fit your diet

Because the cells are still physically present, they actively release hormones signaling your brain that you are starving, triggering intense cravings and a slowed metabolism

This is the trap: GLP-1 medications are not a treatment you finish they are a lifetime subscription

Ozempic is first GLP-1 drug FDA-approved for kidney disease Novo Nordisk's GLP-1 agonist Ozempic has become the first drug in the class to be approved by the FDA to reduce the risk of worsening kidney disease in people with type 2 diabetes

10.1038/ncomms14694 17 HongJ.XuB.HuX.LiuC.LiuH.TianJ.et al (2025)

Compounded versions may not undergo the same rigorous FDA approval process as branded medications like Wegovy or Zepbound